Hematologic Malignancy

Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

Hematologic172 active trials13 approved drugs9 evidence items

NCIt: C3468
DOID: 0050743

Clinical trials

Registered studies

786 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 172
Recruiting: 93
Ph III recruiting: 9
Growth YoY: +32.4%
Industry share: 20%
Top sponsor: Ruijin Hospital
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (129)

No study matches these filters